Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
3
×
inclisiran
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
pcsk9
3
×
regeneron pharmaceuticals
sanofi
3
×
alirocumab
biotech
cholesterol
clinical trials
evolocumab
ldl
mt sinai hospital
new york
praluent
prashant vaishnava
repatha
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
circulation
clinical studies
data
david maron
deals
detroit blog main
detroit top stories
esperion pharmaceuticals
What
cholesterol
drug
lowering
medco
medicines
new
wave
aces
acquire
agreed
announced
big
billion
brings
cash
ceo
company
compound
deal
drugs
expensive
faces
fda
financial
flexible
foe
healthcare
hint
inclisiran
inhibitors
key
known
meant
medicine
nasdaq
novartis
open
passed
pcsk
poised
Language
unset
Current search:
pcsk9
×
inclisiran
×
" boston top stories "
×
sanofi
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)